Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Oral Semaglutide and CV Benefits in the SOUL Trial: How Do Baseline or Changes in HbA1c or BMI Affect Clinical Outcomes?
The Journal of clinical endocrinology and metabolism, 2026
Safety Signals of GLP-1 Receptor Agonists: A Multi-Method Pharmacovigilance Analysis of FAERS (2018-2025) With Sensitivity-Stratified Prioritisation, Notoriety-Bias Assessment, and Cross-Database Validation
Diabetes, obesity & metabolism, 2026
Host-directed treatments for tuberculous meningitis utilizing a multi-platform approach across mouse and human models
Nature communications, 2026;17(1)
Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: multi-target trial emulation study
BMJ open, 2026;16(7):e109259
From FLOW to translational positioning in chronic kidney disease: mechanistic complementarity of SGLT2 inhibitors and GLP-1 receptor agonists
Translational research : the journal of laboratory and clinical medicine, 2026
GLP-1 Receptor Agonists as a Candidate Treatment for Opioid Use Disorder: From rats to humans
Biological psychiatry, 2026
Unconventional Applications of Semaglutide and Tirzepatide: From Oncology to Human Reproduction
Biomedicines, 2026;14(7)
Signal thresholds and causal inference in pharmacovigilance studies of glucagon-like Peptide-1 receptor agonists
Clinical nutrition (Edinburgh, Scotland), 2026;64:106731
Affordable Semaglutide in India: Expanding Access and Unanswered Questions for Children and Special Populations
Indian pediatrics, 2026
Pharmacologic Treatments for MASLD: A Review of Efficacy and Safety Considerations
The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2026;:87551225261466571
Incretin-Based Therapies, Obesity-Associated Inflammation, and Atherosclerotic Cardiovascular Risk
Cells, 2026;15(14)
Linking pediatric obesity to youth-onset type 2 diabetes: integrated longitudinal and cross-sectional evidence from population-based studies worldwide
Clinical and experimental pediatrics, 2026
Letter to the Editor Regarding “Long-Term Mechanical Complications After Lumbar Fusion in Patients Receiving Tirzepatide vs Other GLP-1 Receptor Agonists”
Spine, 2026
Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial
Diabetes, obesity & metabolism, 2026
Therapeutic Benefit or Ocular Risk? Semaglutide and Non-Arteritic Anterior Ischemic Optic Neuropathy: Retraction
Retina (Philadelphia, Pa.);46(8):e95
Semaglutide promotes angiogenesis and blood-brain barrier repair after traumatic brain injury via PDGF-BB/PDGFRβ/Ang1/Tie2/VEGF signaling pathway
Scientific reports, 2026
Evolving utilization of bariatric surgery since the rise of semaglutide and tirzepatide
Surgical endoscopy, 2026
Peripheral artery disease: advances in medical therapy
European heart journal, 2026
Effect of semaglutide on hidradenitis suppurativa disease control and quality of life: A case series
Journal of the European Academy of Dermatology and Venereology : JEADV, 2026
Comparative Cardiovascular Outcomes of Tirzepatide and Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Journal of the American Heart Association, 2026;:e047018